Could a 'Microbiome Transplant' stop recurring vaginal infections?

NCT ID NCT04046900

Recruiting now Disease control Sponsor: Douglas Kwon Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether transplanting vaginal fluid from healthy donors can restore a healthy bacterial balance in women with recurrent bacterial vaginosis (BV). Participants receive either the transplant or a placebo after antibiotic treatment. The goal is to see if the transplant helps maintain protective Lactobacillus bacteria and prevent BV from coming back.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vaginal microbiome transplant (donor vaginal fluid)
What this could lead to: If successful, this approach could offer a new way to prevent recurrent bacterial vaginosis by restoring healthy vaginal bacteria.
What could go wrong: This is an early-phase trial with a small number of participants. The transplant may not take hold, or side effects could occur. Results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates